Skip to content
healthcare.dev
Get a free key

RiVive

NDC 82954-0100, naloxone hydrochloride, spray, from Harm Reduction Therapeutics, Inc..

Product NDC
82954-0100
Status
Listed
Labeler
Harm Reduction Therapeutics, Inc.
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA217722
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82954-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NALOXONE HYDROCHLORIDE3 mg/.1mL

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]

Package NDCNDC-11Package
82954-0100-1829540100012 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1) / .1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82954-0100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82954-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82954-0100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.